Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference84 articles.
1. From COVID-19 research to vaccine application: why might it take 17 months not 17 years and what are the wider lessons?;Hanney;Health Res Policy Sys,2020
2. Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline;Davis;Vaccine,2011
3. Risk in vaccine research and development quantified;Pronker;PLoS One,2013
4. Vaccine R&D success rates and development times;Struck;Nat Biotechnol,1996
5. Innovation policy and the market for vaccines;Xue;J Law Biosci,2020
Cited by 958 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial;Vaccine;2024-11
2. Robust two-dose vaccination schemes and the directed b-matching problem;Discrete Applied Mathematics;2024-10
3. How Were European GPs/FPs Involved in the COVID-19 Vaccination Campaign? A European Questionnaire Study about the Experiences of the Vaccinations in 2021;Healthcare;2024-09-06
4. Sustaining the mobile medical units to bring equity in healthcare: a PLS-SEM approach;International Journal for Equity in Health;2024-09-02
5. Regulation of protein thermal stability and its potential application in the development of thermo-attenuated vaccines;Engineering Microbiology;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3